137 related articles for article (PubMed ID: 6084077)
21. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical identification of macrophages and various dendritic cells in paraffin-embedded biopsy material.
Brandtzaeg P
APMIS Suppl; 1988; 2():136-59. PubMed ID: 3179032
[TBL] [Abstract][Full Text] [Related]
23. Dendritic cells in esophageal cancer and lymph node tissues.
Imai Y; Yamakawa M
In Vivo; 1993; 7(3):239-48. PubMed ID: 8357965
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical demonstration of histiocytes in normal ectocervical epithelium and epithelial lesions of the uterine cervix.
Hachisuga T; Fukuda K; Hayashi Y; Iwasaka T; Sugimori H
Gynecol Oncol; 1989 Jun; 33(3):273-8. PubMed ID: 2656425
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic expression of cells of stationary elements in human lymphoid tissues. A histochemical and immunohistochemical study.
Hsu SM
Hematol Pathol; 1987; 1(1):45-56. PubMed ID: 3504430
[TBL] [Abstract][Full Text] [Related]
26. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.
Cochand-Priollet B; Molinié V; Bougaran J; Bouvier R; Dauge-Geffroy MC; Deslignières S; Fournet JC; Gros P; Lesourd A; Saint-André JP; Toublanc M; Vieillefond A; Wassef M; Fontaine A; Groleau L
Arch Pathol Lab Med; 1997 Oct; 121(10):1081-6. PubMed ID: 9341588
[TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical studies of bronchial carcinoma using monoclonal antibody A63-C/A3].
Weber S; Reinhold-Richter L; Karsten U
Zentralbl Pathol; 1991; 137(4):355-9. PubMed ID: 1768687
[TBL] [Abstract][Full Text] [Related]
28. [Langerhans cells: methods of identification].
Nicolas C; Schmitt D
Pathol Biol (Paris); 1984 Mar; 32(3):199-208. PubMed ID: 6232489
[TBL] [Abstract][Full Text] [Related]
29. Cellular immunolocalization of S100 protein within fixed tissue sections by monoclonal antibodies.
Loeffel SC; Gillespie GY; Mirmiran SA; Miller EW; Golden P; Askin FB; Siegal GP
Arch Pathol Lab Med; 1985 Feb; 109(2):117-22. PubMed ID: 2579618
[TBL] [Abstract][Full Text] [Related]
30. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
31. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
32. Malignant histiocytosis and Letterer-Siwe disease. Neoplasms of T-zone histiocyte with S100 protein.
Watanabe S; Nakajima T; Shimosato Y; Sato Y; Shimizu K
Cancer; 1983 Apr; 51(8):1412-24. PubMed ID: 6687444
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors.
van Muijen GN; Ruiter DJ; Ponec M; Huiskens-van der ; Mey C; Warnaar SO
Am J Pathol; 1984 Jan; 114(1):9-17. PubMed ID: 6197887
[TBL] [Abstract][Full Text] [Related]
34. Localization of interleukin-1 in normal or reactive lymphoid tissues and skin: abundance of IL-1 in interdigitating reticulum cells.
Hsu SM; Zhao X
Lymphokine Res; 1987; 6(1):13-8. PubMed ID: 3546961
[TBL] [Abstract][Full Text] [Related]
35. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
36. Trivariate flow cytometric analysis of paraffin-embedded lung cancer specimens: application of cytokeratin subtype specific antibodies to distinguish between differentiation pathways.
Leers MP; Theunissen PH; Koudstaal J; Schutte B; Ramaekers FC
Cytometry; 1997 Feb; 27(2):179-88. PubMed ID: 9012385
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
38. [Benign clear cell tumor of the lung--a study of immunohistochemistry].
Nakamura T; Muramoto Y; Sato E; Tanaka S; Higashi T; Makino M; Nishimura M
Gan No Rinsho; 1986 Sep; 32(11):1466-70. PubMed ID: 2430120
[TBL] [Abstract][Full Text] [Related]
39. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
